If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIG Regulatory News (SHI)

Share Price Information for SIG (SHI)

Share Price is delayed by 15 minutes
Get Live Data
8.08    -0.67 (-7.66%)
Bid:
8.00
Ask:
8.08
Spread: 0.08 (1.00%)
Market Cap: £93.39m
SHI Live PriceLast checked at - London Stock Exchange

Intraday SIG Share Chart

Pre Stabilisation Notice

2 Nov 2021 13:38

RNS Number : 1012R
HSBC Bank plc
02 November 2021
 

2nd November 2021

 

SIG plc 

Pre Stabilisation Notice

HSBC (contact: 'synd manager'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

SIG plc

Guarantor (if any):

na

Aggregate nominal amount:

EUR 300,000,000

Description:

Fixed 5yr

Offer price:

TBC

Other offer terms:

 

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc

Stabilisation period expected to start on:

4th November 2021

Stabilisation period expected to end no later than:

10th December 2021

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAFZMGMFZKGMZM
Date   Source Headline
15th May 20184:48 pmRNSDirector/PDMR Shareholding
10th May 20184:14 pmRNSResult of AGM
10th May 20182:09 pmRNSDirector Declaration
10th May 20187:43 amRNSDirector Declaration
10th May 20187:00 amRNSAGM Trading Update
17th Apr 20189:33 amRNSDirector/PDMR Shareholding
13th Apr 201811:41 amRNSHolding(s) in Company
11th Apr 20181:42 pmRNSDirector/PDMR Shareholding
5th Apr 20183:33 pmRNSAnnual Financial Report
5th Apr 20181:54 pmRNSHolding(s) in Company
5th Apr 20181:53 pmRNSHolding(s) in Company
5th Apr 20181:53 pmRNSHolding(s) in Company
22nd Mar 20181:17 pmRNSHolding(s) in Company
20th Mar 201811:38 amRNSHolding(s) in Company
16th Mar 201812:04 pmRNSDirector/PDMR Shareholding
12th Mar 20183:09 pmRNSHolding(s) in Company
12th Mar 201810:01 amRNSDirector/PDMR Shareholding
9th Mar 20187:01 amRNSDirectorate Change
9th Mar 20187:00 amRNSFinal Results
28th Feb 20182:19 pmRNSHolding(s) in Company
28th Feb 20187:00 amRNSDisposal of SIG Building Systems
16th Feb 20188:29 amRNSDirector/PDMR Shareholding
9th Feb 201812:48 pmRNSDirector Declaration
7th Feb 20188:24 amRNSBlock listing Interim Review
1st Feb 20187:00 amRNSHistorical overstatement of profit
26th Jan 20188:59 amRNSHolding(s) in Company
16th Jan 201811:01 amRNSDirector/PDMR Shareholding
9th Jan 20187:00 amRNSTrading Update and Chair of Remuneration Committee
3rd Jan 20181:10 pmRNSTrading Statement
2nd Jan 201810:05 amRNSTotal Voting Rights
15th Dec 20174:54 pmRNSDirector/PDMR Shareholding
7th Dec 20178:20 amRNSHolding(s) in Company
4th Dec 201711:57 amRNSDirector/PDMR Shareholding
4th Dec 201710:12 amRNSDirector/PDMR Shareholding
27th Nov 20179:51 amRNSHolding(s) in Company
21st Nov 20177:00 amRNSTrading Update and Strategy Day
17th Nov 20179:00 amRNSDirector/PDMR Shareholding
15th Nov 20172:39 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSChange of Adviser
30th Oct 20172:24 pmRNSHolding(s) in Company
17th Oct 20179:06 amRNSDirector/PDMR Shareholding
12th Oct 20177:00 amRNSTrading Update and Strategy Day
11th Oct 20177:00 amRNSDirectorate Change
18th Sep 20178:38 amRNSDirector/PDMR Shareholding
1st Sep 20178:53 amRNSTotal Voting Rights
23rd Aug 20175:18 pmRNSDirector/PDMR Shareholding
16th Aug 20178:55 amRNSDirector/PDMR Shareholding
15th Aug 20179:22 amRNSDirector/PDMR Shareholding
14th Aug 20172:33 pmRNSHolding(s) in Company
8th Aug 20179:52 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.